OAM
Origin Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-2,600
| Closed | -$1.45M | – | 111 |
|
|
2021
Q2 | $1.45M | Hold |
2,600
| – | – | 0.16% | 52 |
|
|
2021
Q1 | $1.23M | Sell |
2,600
-100
| -4% | -$47.3K | 0.13% | 64 |
|
|
2020
Q4 | $1.3M | Hold |
2,700
| – | – | 0.12% | 64 |
|
|
2020
Q3 | $1.51M | Sell |
2,700
-800
| -23% | -$448K | 0.16% | 48 |
|
|
2020
Q2 | $2.18M | Sell |
3,500
-300
| -8% | -$187K | 0.32% | 42 |
|
|
2020
Q1 | $1.86M | Buy |
+3,800
| New | +$1.86M | 0.24% | 48 |
|
|
2019
Q2 | – | Sell |
-54,250
| Closed | -$22.3M | – | 131 |
|
|
2019
Q1 | $22.3M | Buy |
54,250
+17,000
| +46% | +$6.98M | 1.86% | 13 |
|
|
2018
Q4 | $13.9M | Buy |
37,250
+1,050
| +3% | +$392K | 1.27% | 32 |
|
|
2018
Q3 | $14.6M | Buy |
+36,200
| New | +$14.6M | 0.95% | 47 |
|
|
2016
Q1 | – | Sell |
-50,425
| Closed | -$27.4M | – | 146 |
|
|
2015
Q4 | $27.4M | Buy |
50,425
+11,650
| +30% | +$6.32M | 2.22% | 10 |
|
|
2015
Q3 | $18M | Buy |
+38,775
| New | +$18M | 1.49% | 22 |
|